Nathalie Compagnone
Director Ejecutivo en Innovative Concepts in Drug Development SAS .
Perfil
Nathalie Compagnone is the founder and currently holds the position of Chief Executive & Scientific Officer at Innovative Concepts in Drug Development SAS, which she founded in 2007.
She previously worked as Head-Laboratory at The University of California, San Francisco and as Principal at Trophos SA. Dr. Compagnone holds an MBA degree from Rutgers State University of New Jersey and an undergraduate degree from Université de Franche-Comté.
Cargos activos de Nathalie Compagnone
| Empresas | Cargo | Inicio |
|---|---|---|
Innovative Concepts in Drug Development SAS
 Innovative Concepts in Drug Development SAS BiotechnologyHealth Technology Innovative Concepts in Drug Development SAS develops and provides innovative proprietary screening platforms to the pharmaceutical development sector. The company was founded by Natahlie Compagnone in 2007 and is headquartered in Gemenos, France. | Director Ejecutivo | 01/01/2007 |
Antiguos cargos conocidos de Nathalie Compagnone.
| Empresas | Cargo | Fin |
|---|---|---|
Trophos SA
 Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Corporate Officer/Principal | - |
| The University of California, San Francisco | Corporate Officer/Principal | - |
Formación de Nathalie Compagnone.
| Université de Franche-Comté | Undergraduate Degree |
| Rutgers State University of New Jersey | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Health Technology |
Innovative Concepts in Drug Development SAS
Innovative Concepts in Drug Development SAS BiotechnologyHealth Technology Innovative Concepts in Drug Development SAS develops and provides innovative proprietary screening platforms to the pharmaceutical development sector. The company was founded by Natahlie Compagnone in 2007 and is headquartered in Gemenos, France. | Health Technology |
- Bolsa de valores
- Insiders
- Nathalie Compagnone
